Stock Events

Stock Events

Glenmark Pharmaceuticals (GLENMARK.NSE) Q1 2026 Earnings

Jan 29Confirmed

Q2 2025

Q3 2025

Q4 2025

Q1 2026

1.69

8.32

14.95

21.57

Details

Expected EPS

19.094077021249998

Actual EPS

14.5809315435

Surprise EPS

-4.51

Surprise Percent

-23.64%

Description

⁨Glenmark Pharmaceuticals⁩ (⁦GLENMARK.NSE⁩) has reported earnings of ⁦14.5809315435⁩ per share for ⁦Q1 2026⁩.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.